As endocrine disorders are on the rise, it's important for primary care providers take a role in patient management. CGM has the opportunity to improve the lives of patients with endocrine disorders. Our Exploring CGM course will orient PCPs with CGM devices via guided explanations from faculty along with hands-on time with available devices to increase their knowledge of CGM as a tool, their confidence in discussing the CGM data with their patients, and competence in integrating CGM tools into their clinical practice.
CME Credits: 1
CLICK TO REGISTER FOR FREE
MOC Credits: 1
Upon completion of the activity, participants should be able to:
- Review traditional approaches to monitoring glucose
- Discuss continuous glucose monitoring and the role it plays in type 2 diabetes (T2D)
- Select the appropriate kind of CGM for the individual person
- Incorporate CGM into the multi-disciplinary clinical management of the person with diabetes
Anne L. Peters, MD
Professor of Medicine
Keck School of Medicine of USC
Los Angeles, CA
Jay H. Shubrook DO, FACOFP, FAAFP
Jane Jeffrie Seley, DNP, MSN, MPH, GNP, CDE, BC-ADM, CDTC, FAADE, FAAN
Primary Care Department
Director of Clinical Research and Diabetes Services
Touro University California
Program Manager & NP, Inpatient Glycemic Control Program
New York-Presbyterian Hospital/ Weill Cornell Medicine
New York, NY
This activity is provided by American College of Endocrinology in collaboration with The France Foundation.
This educational initiative is intended for primary care clinicians who care for patients with diabetes.
Statement of Need
Advancements in science, such as continuous glucose monitoring (CGM) devices, hold great promise in empowering healthcare providers and patients in controlling T2D. Yet, research tells us that our healthcare providers, especially primary care providers, are challenged in keeping up with these advancements.
The American Association of Clinical Endocrinologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Endocrinology designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses who are certified by the American Nurses Credentialing Center (ANCC) may utilize activities that are certified by ACCME-accredited providers toward their requirement for certification renewal by the ANCC. A certificate of attendance will be provided by The American College of Endocrinology, an ACCME accredited provider.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC Medical Knowledge point(s) in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point(s) equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
Disclosures/Conflicts of Interest
In accordance with the ACCME Standards for Commercial Support, The American Association of Clinical Endocrinology (AACE) and The France Foundation (TFF) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. AACE and TFF resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, AACE and TFF seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. AACE and TFF are committed to providing learners with high-quality CME.
Activity Staff Disclosures
The planners, reviewers, editors, staff, CME committee, and other members at the American Association of Clinical Endocrinology who control content have no relevant financial relationships to disclose.
The planners, reviewers, editors, staff, CME committee, and other members at The France Foundation who control content have no relevant financial relationships to disclose.
The faculty listed below report that they have relevant financial relationships to disclose:
- Anne Peters, MD, serves on advisory boards for Abbott Diabetes Care, Lilly, NovoNordisk, AstraZeneca, Vertex, Medscape, and Zealand. She does research funded by Dexcom, Insulet, and Abbott Diabetes Care. She also reports stock options for Omada Health and Teladoc.
- Jay Shubrook, DO, FACOFP, FAAFP, serves on an advisory board for Bayer, NovoNordisk, and Sanofi
The following faculty report that they have no relevant financial relationships to disclose:
- Jane Jeffrie Seley, DNP, MSN, MPH, GNP, CDE, BC-ADM, CDTC, FAADE, FAAN
Disclosure of Unlabeled Use
AACE and TFF require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. AACE and TFF do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
This activity is supported by an educational grant from Abbott Diabetes Care, Lilly, and Medtronic.
The American Association of Clinical Endocrinology and The France Foundation present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The American Association of Clinical Endocrinology, The France Foundation, and the commercial supporter(s) assume no liability for the information herein.
Live presentations of the CGM activity will be presented at the following conferences:
10/1/2021 Arkansas Academy of Physician Assistants
10/6/2021 Tennessee Academy of Physician Assistants
10/13/2021 Utah Nurse Practitioner Association
10/21/2021 Mississippi Nurses Association
11/11/2021 Georgia Academy of Family Physicians
3/17/2022 Louisiana Academy of Physician Assistants
3/17-20/2022 American College of Osteopathic Family Physicians Annual Meeting